Modulation of articular chondrocyte proliferation and anionic glycoconjugate synthesis by glucosamine (GlcN), N-acetyl GlcN (GlcNAc) GlcN sulfate salt (GlcN.S) and covalent glucosamine sulfates (GlcN-SO4)

Osteoarthritis and Cartilage

Volumn 15, Issue 8, 2007, Pages 946-956

  Terry, D E ^a   Rees Milton, K ^a   Pruss, C ^a   Hopwood, J ^a   Carran, J ^a   Anastassiades, T P ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Cartilage; Chondrocyte; Glucosamine; Osteoarthritis

Indexed keywords

ALGINIC ACID; COLLAGEN TYPE 1; DNA; FIBRONECTIN; GLUCOSAMINE; GLUCOSAMINE SULFATE; GLUCOSE; GLYCOCONJUGATE; INOSINE; N ACETYLGLUCOSAMINE; PROTEOGLYCAN; SULFUR 35;

ACETYLATION; ANIMAL CELL; ARTICLE; CARTILAGE CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; COW; DNA SYNTHESIS; INHIBITION KINETICS; NONHUMAN; PRIORITY JOURNAL; PROTEOGLYCAN SYNTHESIS; SULFATION; TISSUE SPECIFICITY;

ACETYLGLUCOSAMINE; ALGINATES; ANIMALS; ANIONS; CARTILAGE, ARTICULAR; CATTLE; CELL ADHESION; CELL COUNT; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; CHONDROCYTES; CULTURE MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOSAMINE; GLUCURONIC ACID; GLYCOCONJUGATES; HEXURONIC ACIDS; MICROSPHERES; PROTEOGLYCANS;

EID: 34547660731     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2007.02.010     Document Type: Article

References (37)

1. Towheed T.E., Anastassiades T.P., Shea B., Houpt J., Welch V., and Hochberg M. Glucosamine therapy for treating osteoarthritis. Chochrane Database Syst Rev (2005) (2):CD002946
2. Russell A.S., Aghazadeh-Habashi A., and Jamali F. Active ingredient consistency of commercially available glucosamine sulfate products. J Rheumatol 29 11 (Nov 2002) 2407-2409
3. Setnikar I., Palumbo R., Canali S., and Zanolo G. Pharmacokinetics of glucosamine in man. Arzneim Forsch 43 (1993) 1109-1113
4. Aghazadeh-Habashi J.A., Sattari S., Pasutto F., and Jamali F. High performance liquid chromatographic determination of glucosamine in rat plasma. J Pharm Pharm Sci 5 (2002) 176-180
5. Aghazadeh-Habashi A., Sattari S., Pasutto F., and Jamali F. Single dose pharmacokinetics and bioavailability of glucosamine in the rat. J Pharm Pharm Sci 5 (2002) 181-184
6. Laverty S., Sandy J.D., Celeste C., Vachon P., Marier J.F., and Plaas A.H. Synovial fluid levels and serum pharmacokinetics in a large animal model following treatment with oral glucosamine at clinically relevant doses. Arthritis Rheum 52 1 (2005) 181-191
7. Friedman S.J., and Skehan P. Membrane-active drugs potentiate the killing of tumor cells by D-glucosamine. Proc Natl Acad Sci U S A 77 (1980) 1172-1176
8. Marshall S., Bacote V., and Traxinger R.R. Discovery of a metabolic pathway mediating glucose-induced desensitization of the transport system. Role of hexosamine biosynthesis in the induction of insulin resistance. J Biol Chem 266 (1991) 4706-4712
9. Sandy J.D., Thompson V., Verscharen C., and Gamett D. Chondrocyte-mediated catabolism of aggrecan: evidence for a glycosylphosphatidylinositol-linked protein in the aggrecanse response to interleukin-1 or retinoic acid. Arch Biochem Biophys 367 (1999) 258-264
10. Patwari P., Kurz B., Sandy J.D., and Grodzinsky A.J. Mannosamine inhibits aggrecanase-mediated changes in the physical properties and biochemical composition of articular cartilage. Arch Biochem Biophys 374 (2000) 79-85
11. Fenton J.I., Chlebek-Brown K.A., Peters T.L., Caron J.P., and Orth M.W. Glucosamine HCl reduces equine articular cartilage degradation in explant culture. Osteoarthritis Cartilage 8 (2000) 258-265
12. Dodge G.R., and Jimenez S.A. Glucosamine sulfate modulates the levels of aggrecan and matrix metalloproteinase-3 synthesized by cultured human osteoarthritis articular chondrocytes. Osteoarthritis Cartilage 11 (2003) 424-443
13. Nakamura H., Shibakawa A., Tanaka M., Kato T., and Nishioka K. Effects of glucosamine hydrochloride on the production of prostaglandin E2, nitric oxide and metalloproteases by chondrocytes and synoviocytes in osteoarthritis. Clin Exp Rheumatol 22 3 (2004) 293-299
14. Terry D.E., Rees-Milton K., Smith P., Carran J., Pezeshki P., Woods C., et al. N-acylation of glucosamine modulates chondrocyte growth, proteoglycan synthesis, and gene expression. J Rheumatol 32 9 (Sep 2005) 1775-1786
15. Gardell S. Determination of hexosamines. Methods Biochem Anal 6 (1958) 289-317
16. Chan C., and Anastassiades T. Anionic glycoconjugates from differentiated and dedifferentiated cultures of bovine articular chondrocytes: modulation by TGF-β. In Vitro Cell Dev Biol 34 (1998) 492-498
17. Stewart C.C. Multiparameter analysis of leukocytes by flow cytometry. In: Darzynkiewicz Z., and Crissman H.A. (Eds). Methods in Cell Biology 33 (1990), Academic Press, Inc, New York 427-450
18. Chopra R., and Anastassiades T. Specificity and synergism of polypeptide growth factors in stimulating the synthesis of proteoglycans and a novel high molecular weight anionic glycoprotein by articular chondrocyte cultures. J Rheumatol 25 (1998) 1578-1584
19. Hronowski L., and Anastassiades T. Quantitation and interaction of glycosaminoglycans with alcian blue in dimethyl sulfoxide solutions. Anal Biochem 93 1 (1979) 60-72
20. Elima K., and Vuorio E. Expression of mRNAs for collagens and other matrix components in differentiating and dedifferentiating human chondrocytes in culture. FEBS Lett 258 2 (1989) 195-198
21. 10 protein segments. J Biol Chem 271 31 (1996) 18954-18960
22. Rees-Milton K.J., Terry D., and Anastassiades T.P. Hyperglycosylation of fibronectin by TGF-beta1-stimulated chondrocytes. Biochem Biophys Res Commun 317 3 (2004) 844-850
23. Hiraku Y., and Kawanishi S. Involvement of oxidative DNA damage and apoptosis in antitumor actions of aminosugars. Free Radic Res 31 5 (1999) 389-403
24. D'Lima D.D., Kuhn K., and Lotz M.K. Detection of apoptosis in cartilage in situ and in isolated chondrocytes. In: Sabatini M., Pastoureau P., and DeCeuninck F. (Eds). Cartilage and Osteoarthritis. : Cellular and Molecular Tools. Methods in Molecular Medicine Volume 100/Volume 1 (2004), Humana Press Inc, Tolowa, NJ 275-289
25. Windhaber R.A., Wilkins R.J., and Meredith D. Functional characterization of glucose transport in bovine articular chondrocytes. Pflugers Arch. Epub 446 5 (2003) 572-577
26. Broschat K.O., Gorka C., Page J.D., Martin-Berger C.L., Davies M.S., Huang H.C., et al. Kinetic characterization of human glutamine-fructose-6-phosphate amidotransferase I: potent feedback inhibition by glucosamine 6-phosphate. J Biol Chem 277 17 (Apr 26 2002) 14764-14770 Epub 2002 Feb 12
27. Weigert C., Brodbeck K., Lehmann R., Haring H.U., and Schleicher E.D. Overexpression of glutamine:fructose-6-phosphate-amidotransferase induces transforming growth factor-beta1 synthesis in NIH-3T3 fibroblasts. FEBS Lett 488 1-2 (Jan 12 2001) 95-99
28. Frazer A., Bunning R.A., and Russell R.G. Effects of transforming growth factor beta and interleukin-1 beta on [3H]thymidine incorporation by human articular chondrocytes in vitro. Biochim Biophys Acta 1226 2 (May 25 1994) 193-200
29. Chan C.K., and Anastassiades T.P. Stimulatory effect of TGF-beta on anionic glycoconjugate synthesis by rat calvarial cells: specificity, uncoupling of cell density dependence, and modulation by chondroitin sulfate. J Bone Miner Res 8 11 (Nov 1993) 1301-1309
30. Barbero A., Palumberi V., Wagner B., Sader R., Grote M.J., and Martin I. Experimental and mathematical study of the influence of growth factors on the growth kinetics of adult human articular chondrocytes. J Cell Physiol 3 (Sep 2005) 830-838
31. Gibson G., Lin D.L., Wang X., and Zhang L. The release and activation of transforming growth factor beta2 associated with apoptosis of chick hypertrophic chondrocytes. J Bone Miner Res 16 12 (Dec 2001) 2330-2338
32. Clegg D.O., Reda D.J., Harris C.L., Klein M.A., and O'Dell J.R. BMP-2 prevents apoptosis of the N1511 chondrocytic cell line through PI3K/Akt-mediated NF-kappaB activation. J Bone Miner Metab 23 6 (2005) 411-419
33. Piepoli T., Zanelli T., Letari O., Persiani S., Rovati L.C., and Caselli G. Glucosamine sulfate inhibits IL-1 stimulated gene expression at concentrations found in human plasma after oral intake. Osteoarthritis Cartilage 13 Suppl A (2005) S151
34. Shriver Z., Raguram S., and Sasisekharan R. Glycomics: a pathway to a class of new and improved therapeutics. Nat Rev Drug Discov 3 10 (Oct 2004) 863-873
35. Clegg D.O., Reda D.J., Harris C.L., Klein M.A., O'Dell J.R., Hooper M.M., et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med 354 8 (Feb 23 2006) 795-808
36. Herrero-Beaumont G, Román JA, Trabado MC, Blanco FJ, Benito P, Martin-Mola E, et al. Effects of glucosamine sulfate on 6-month control of knee osteoarthritis symptoms vs placebo and acetaminophen: results from the Glucosamine Unum in Die Efficacy (GUIDE) Trial. Arthritis Rheum 54:9(Suppl) S673.
37. Varghese S., Theprungsirikul P., Sahani S., Hwang N., Yarema K.J., and Elisseeff J.H. Glucosamine modulates chondrocyte proliferation, matrix synthesis, and gene expression. Osteoarthritis Cartilage (Jul 15 2006)